Ignite Creation Date:
2025-12-24 @ 10:41 PM
Ignite Modification Date:
2026-03-27 @ 1:29 PM
Study NCT ID:
NCT00759135
Status:
COMPLETED
Last Update Posted:
2012-06-14
First Post:
2008-09-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)
Sponsor:
Nymox Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NX02-0016
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None